203 related articles for article (PubMed ID: 16157204)
1. Cytogenetic findings in clear cell chondrosarcoma.
Nishio J; Reith JD; Ogose A; Maale G; Neff JR; Bridge JA
Cancer Genet Cytogenet; 2005 Oct; 162(1):74-7. PubMed ID: 16157204
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetic and spectral karyotype analyses of benign and malignant cartilage tumours.
Sjögren H; Orndal C; Tingby O; Meis-Kindblom JM; Kindblom LG; Stenman G
Int J Oncol; 2004 Jun; 24(6):1385-91. PubMed ID: 15138578
[TBL] [Abstract][Full Text] [Related]
3. Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.
Tallini G; Dorfman H; Brys P; Dal Cin P; De Wever I; Fletcher CD; Jonson K; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Samson I; Sciot R; Van den Berghe H; Vanni R; Willén H
J Pathol; 2002 Feb; 196(2):194-203. PubMed ID: 11793371
[TBL] [Abstract][Full Text] [Related]
4. Evidence of an association between 6q13-21 chromosome aberrations and locally aggressive behavior in patients with cartilage tumors.
Sawyer JR; Swanson CM; Lukacs JL; Nicholas RW; North PE; Thomas JR
Cancer; 1998 Feb; 82(3):474-83. PubMed ID: 9452264
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous interphase cytogenetic analysis and fluorescence immunophenotyping of dedifferentiated chondrosarcoma. Implications for histopathogenesis.
Bridge JA; DeBoer J; Travis J; Johansson SL; Elmberger G; Noel SM; Neff JR
Am J Pathol; 1994 Feb; 144(2):215-20. PubMed ID: 8311109
[TBL] [Abstract][Full Text] [Related]
6. Translocation der(13;21)(q10;q10) in skeletal and extraskeletal mesenchymal chondrosarcoma.
Naumann S; Krallman PA; Unni KK; Fidler ME; Neff JR; Bridge JA
Mod Pathol; 2002 May; 15(5):572-6. PubMed ID: 12011263
[TBL] [Abstract][Full Text] [Related]
7. [Cytogenetic changes in low grade central osteosarcomas].
Werner M; Rieck J; Delling G
Verh Dtsch Ges Pathol; 1998; 82():189-94. PubMed ID: 10095432
[TBL] [Abstract][Full Text] [Related]
8. Der(16)t(1;16)(q21;q13) as a secondary structural aberration in yet a third sarcoma, extraskeletal myxoid chondrosarcoma.
Day SJ; Nelson M; Rosenthal H; Vergara GG; Bridge JA
Genes Chromosomes Cancer; 1997 Dec; 20(4):425-7. PubMed ID: 9408761
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma.
Klatte T; Rao PN; de Martino M; LaRochelle J; Shuch B; Zomorodian N; Said J; Kabbinavar FF; Belldegrun AS; Pantuck AJ
J Clin Oncol; 2009 Feb; 27(5):746-53. PubMed ID: 19124809
[TBL] [Abstract][Full Text] [Related]
10. t(9;22)(q22-31;q11-12) is a consistent marker of extraskeletal myxoid chondrosarcoma: evaluation of three cases.
Sciot R; Dal Cin P; Fletcher C; Samson I; Smith M; De Vos R; Van Damme B; Van den Berghe H
Mod Pathol; 1995 Sep; 8(7):765-8. PubMed ID: 8539235
[TBL] [Abstract][Full Text] [Related]
11. Comparative genomic hybridization in cartilaginous tumors.
Ozaki T; Wai D; Schäfer KL; Lindner N; Böcker W; Winkelmann W; Dockhorn-Dworniczak B; Poremba C
Anticancer Res; 2004; 24(3a):1721-5. PubMed ID: 15274346
[TBL] [Abstract][Full Text] [Related]
12. Genomic profiling of chondrosarcoma: chromosomal patterns in central and peripheral tumors.
Hallor KH; Staaf J; Bovée JV; Hogendoorn PC; Cleton-Jansen AM; Knuutila S; Savola S; Niini T; Brosjö O; Bauer HC; Vult von Steyern F; Jonsson K; Skorpil M; Mandahl N; Mertens F
Clin Cancer Res; 2009 Apr; 15(8):2685-94. PubMed ID: 19336518
[TBL] [Abstract][Full Text] [Related]
13. Clear cell sarcoma case report: complex karyotype including t(12;22) in primary and metastatic tumor.
Henkle CT; Hawkins AL; McCarthy EF; Griffin CA
Cancer Genet Cytogenet; 2004 Feb; 149(1):63-7. PubMed ID: 15104285
[TBL] [Abstract][Full Text] [Related]
14. Array-comparative genomic hybridization of central chondrosarcoma: identification of ribosomal protein S6 and cyclin-dependent kinase 4 as candidate target genes for genomic aberrations.
Rozeman LB; Szuhai K; Schrage YM; Rosenberg C; Tanke HJ; Taminiau AH; Cleton-Jansen AM; Bovée JV; Hogendoorn PC
Cancer; 2006 Jul; 107(2):380-8. PubMed ID: 16779802
[TBL] [Abstract][Full Text] [Related]
15. Clear cell sarcoma associated with multiple pulmonary metastases with structural and numerical karyotypic changes.
Kato N; Mizuno O; Tamura A; Yamanaka Y; Tanimura S; Minakawa H
Clin Exp Dermatol; 2004 Nov; 29(6):614-6. PubMed ID: 15550135
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic findings in 19 malignant bone tumors.
Ozisik YY; Meloni AM; Peier A; Altungoz O; Spanier SS; Zalupski MM; Leong SP; Sandberg AA
Cancer; 1994 Oct; 74(8):2268-75. PubMed ID: 7922978
[TBL] [Abstract][Full Text] [Related]
17. Dedifferentiated chondrosarcoma with t(9;22)(q34;q11-12).
Tarkkanen M; Wiklund T; Virolainen M; Elomaa I; Knuutila S
Genes Chromosomes Cancer; 1994 Feb; 9(2):136-40. PubMed ID: 7513544
[TBL] [Abstract][Full Text] [Related]
18. The pericentromeric inversion, inv (6)(p25q13), is a novel diagnostic marker in chondromyxoid fibroma.
Granter SR; Renshaw AA; Kozakewich HP; Fletcher JA
Mod Pathol; 1998 Nov; 11(11):1071-4. PubMed ID: 9831204
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic analysis of a low-grade secondary peripheral chondrosarcoma arising in synovial chondromatosis.
Kyriazoglou AI; Rizou H; Dimitriadis E; Arnogiannaki N; Agnantis N; Pandis N
In Vivo; 2013; 27(1):57-60. PubMed ID: 23239852
[TBL] [Abstract][Full Text] [Related]
20. Evidence for telomeric fusions as a mechanism for recurring structural aberrations of chromosome 11 in giant cell tumor of bone.
Sawyer JR; Goosen LS; Binz RL; Swanson CM; Nicholas RW
Cancer Genet Cytogenet; 2005 May; 159(1):32-6. PubMed ID: 15860354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]